Pharma Pricing Strategy
California’s Medicaid pharmacy “carve-out” set to boost state’s negotiating power, introduce IRP for drugs
California is planning a major overhaul of its Medicaid Pharmacy benefit, called Medi-Cal Rx, that will result in a "carve-out"…
Trend towards HTA collaboration boosts need for data
The rising popularity of health technology assessments (HTAs) and similar framework agreements is presenting new challenges for the pharmaceutical industry.…
ESG permeates pharmaceutical pricing strategy
As ESG criteria gains greater traction across the pharmaceutical landscape, the push for pricing sustainability is growing more forceful. To…
Germany’s ESG Law: A case study for new pharma pricing model
Pharmaceutical pricing is increasingly becoming a broader topic in the global push towards sustainability and environmental, social, and government (ESG)…
Canada’s PMPRB reform delays add uncertainty
The government of Canada has once again decided to delay the implementation of the major drug pricing reforms that were…